Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: United Kingdom Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20054
20062
20072
20082
20103
20111
20122
20138
20141
20152
20161
20172
20181
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals17
Bristol-Myers Squibb5
Pfizer5
Teva Branded Pharmaceutical Products R&D, Inc.2
Ariad Pharmaceuticals1
Cell Medica Ltd1
European Society for Blood and Marrow Transplantation1
Gamida Cell ltd1
Imperial College London1
Incyte Biosciences UK1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive38
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Leukemia6
Leukemia, Myeloid, Acute5
Bone Marrow Diseases4
Hematologic Diseases4
Leukemia, Myeloid4
Philadelphia Chromosome4
Hematologic Neoplasms3
Blast Crisis2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.